SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-032460
Filing Date
2021-05-13
Accepted
2021-05-13 19:20:16
Documents
2
Period of Report
2021-05-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 10408
2 POA DOCUMENT poa.txt EX-24.3_984879 3109
  Complete submission text file 0001209191-21-032460.txt   14779
Mailing Address
Business Address
SEIDENBERG BETH C (Reporting) CIK: 0001184592 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40407 | Film No.: 21921363

Mailing Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650-770-0077
Vera Therapeutics, Inc. (Issuer) CIK: 0001831828 (see all company filings)

IRS No.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences